R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model

This publication has 12 references indexed in Scilit:

• Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities
  Psychopharmacology, 2003
• Stress-induced vocalisation in adult animals. A valid model of anxiety?
  European Journal of Pharmacology, 2003
• Fixed-Dose Trial of the Single Isomer SSRI Escitalopram in Depressed Outpatients
  The Journal of Clinical Psychiatry, 2002
• Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials
  CNS Spectrums, 2002
• Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine
  Biological Psychiatry, 2001
• Escitalopram (S-Enantiomer of Citalopram): Clinical Efficacy and Onset of Action Predicted from a Rat Model
  Basic & Clinical Pharmacology & Toxicology, 2001
• Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models
  European Journal of Pharmacology, 1996
• The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
• Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets
  European Journal of Pharmacology: Molecular Pharmacology, 1991
• Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes
  European Journal of Pharmacology, 1985